Characterisation of the affinity of different anabolics and synthetic hormones to the human androgen receptor, human sex hormone binding globulin and to the bovine progestin receptor

APMIS, Supplement

Volumn 109, Issue 103, 2001, Pages

  Bauer, E R S ^a   Daxenberger, A ^a   Petri, T ^a   Sauerwein, H ^a   Meyer, H H D ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Endocrine disruptors; Melengestrol acetate; Receptor affinity; Synthetic hormones; Trenbolone acetate

Indexed keywords

16ALPHA ETHYL 21 HYDROXY 19 NORPREGN 4 ENE 3,20 DIONE; ANABOLIC AGENT; ANDROGEN RECEPTOR; ANDROSTANOLONE; DRUG METABOLITE; GROWTH PROMOTOR; HORMONE DERIVATIVE; MELENGESTROL ACETATE; PROGESTERONE RECEPTOR; SEX HORMONE BINDING GLOBULIN; TRENBOLONE; TRENBOLONE ACETATE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; BINDING AFFINITY; BIODEGRADATION; CONFERENCE PAPER; DRUG ACTIVITY; DRUG DISTRIBUTION; DRUG POTENCY; DRUG RECEPTOR BINDING; NONHUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY;

EID: 0034924270     PISSN: 0903465X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0463.2001.tb05797.x     Document Type: Conference Paper

References (36)

1. Male reproductive health and environmental xenoestrogens
2. Use of MGA (melengestrol acetate) in animal production
3. Plasma ovarian hormone levels and fertility in beef heifers treated with melengestrol acetate (MGA)
4. Control of illegal medroxyprogesterone acetate - Application in veal calves by residue analysis in adipose tissue using HPLC/RIA methods
5. The metabolism of melengetrol acetate
6. Evidence for sex-dependent anabolic response to androgenic steroids mediated by muscle glucocorticoid receptors in the rat
7. Differences in the biotransformation of a 17β-hydroxylated steroid, trenbolone acetate, in rat and cow
8. Reversible binding of the anabolic steroid trenbolone to steroid receptors
9. The degradation of DES in calves excrement-slurry
10. Steroid hormones as water pollutants II. Studies on the persistence and stability of natural urinary and synthetic ovulation-inhibiting hormones in untreated and treated wastewaters
11. Characterisation of human androgen receptor overexpressed in the baculovirus system
12. Production of recombinant androgen receptor in a heterologous expression system
13. Characterisation and expression of a cDNA encoding the human androgen receptor
14. Androgen and estrogen receptors in bovine skeletal muscle: Relation to steroid induced allometric muscle growth
15. Measurement of protein using bicinchoninic acid
16. Application of an androgen receptor assay for the characterisation of the androgenic or antiandrogenic activity of various phenylurea herbicides and their derivatives
17. Dynamics of oxytocin, estrogen and progestin receptors in the bovine endometrium during the estrous cycle
18. Inhibition of androgen receptor binding by natural and synthetic steroids in cultured human genital skin fibroblasts
19. Androgen receptor in human skin fibroblasts, characterisation of a specific 17b-hydroxy-5a-androstan-3-one-protein complex in cell sonicates and nuclei
20. Exchange assay for androgen receptors in the presence of molybdate
21. Binding of progestagens to receptor proteins in MCF-7 cells
22. 5α-Reduction of norethisterone enhances its binding affinity for androgen receptors but diminishes its androgenic potency
23. The mechanism of action of progesterone
24. Relative binding affinities of testosterone, 19-nortestosterone and their 5 alpha-reduced derivatives to the androgen receptor and to other androgen-binding proteins: A suggested role of 5 alpha-reductive steroid metabolism in the dissociation of "myotropic" and "androgenic" activities of 19-nortestosterone
25. Binding of steroid hormones and anabolic agents to bovine sex-hormone binding globulin
26. Sex hormone-binding globulin: Anatomy and physiology of a new regulatory system
27. The use of radioactive 7 alpha, 17 alpha-dimethyl-19-nortestosterone (mibolerone) in the assay of androgen receptors
28. Characterization of the calf uterine androgen receptor and its activation to the deoxyribonucleic acid-binding state
29. Clinical uses of antiandrogens
30. Androgen receptor agonist activity of the synthetic progestin, medroxyprogesterone acetate, in human breast cancer cells
31. Distinguishing androgen receptor agonists and antagonists: Distinct mechanisms of activation by medroxyprogesterone acetate and dihydrotestosterone
32. Multiple actions of synthetic "progestins" on the growth of ZR-75-1 breast cancer cells: An in vitro model for the simultaneous assay of androgen, progestin, estrogen, and glucocorticoid agonistic and antagonistic activities of steroids
33. Metabolism and receptor binding of nandrolone and testesterone under in vitro and in vivo conditions